Background Liver resection is a major surgery with significant mortality and morbidity.
Specialists have tested various methods in attempts to limit blood loss, transfusion …

New blood formation or angiogenesis has become a key target in therapeutic strategies
aimed at inhibiting tumor growth and other diseases associated with neovascularization …

Background Blood loss during liver resection is considered one of the most important factors
affecting the peri‐operative outcomes of patients undergoing liver resection. Objectives To …

The relationship between cancer and coagulopathy was suggested by Trousseau nearly
150 years ago. Later, it became more evident that oncologic patients are at a higher risk of …

The purpose of this review is to demonstrate the potential for development of coagulation-
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …

Background Blood loss during liver resection is one of the most important factors affecting
the peri‐operative outcomes of patients undergoing liver resection. Objectives To determine …

Metastatic disease is responsible for most of cancer lethality. A main obstacle for therapy of
advanced cancers is that the outcome of metastasis depends on a complex interplay …

Objective: Both ibuprofen and tranexamic acid were tried to treat colorectal carcinoma,
however, combined drugs were not. Accordingly, with the aid of SciFinder®, online absence …

The urokinase-type plasminogen activator-plasmin system plays an important role in many
normal physiological processes including clot lysis, wound healing, embryogenesis and …

This overview of the coagulation biology of cancer is intended primarily for those unfamiliar
with the link between the coagulation mechanism and neoplasia. Because the literature on …